Disrupting Markets Through Innovation

WHO WE ARE

Event Capital Strategies seeks to invest broadly in healthcare. We were founded on the premise that a significant opportunity exists to disrupt the healthcare sector through new technologies and business model innovation. 

STRATEGY

Our investment strategy is thematic and backed by our unique perspective, bold ideas, global network, and decades of experience acquiring and operating companies. We target large addressable and consolidated markets which can be disrupted through innovation.

WE ARE FOCUSED ON BUT NOT LIMITED TO

  • Medication Management
  • Orthopedics
  • Life Sciences
  • Diagnostics
  • Healthcare IT & Service

INVESTMENTS

EXPERTISE & APPROACH

Event Capital Strategies supports our platform investments through a robust team of operating partners who have come from leading healthcare and pharmaceutical companies or are medical doctors. We provide hands on strategic and functional support to our portfolio companies and standby to work alongside management as partners or temporarily fill management gaps when needed. Our operating team also enables Event to stand up businesses and carveouts more efficiently and rapidly and drive synergy across our portfolio. 

Returns in our portfolio are derived directly from the execution of our investment strategy and from fundamental improvements—operational, managerial, financial—that we enable during our ownership period.

Our investments may be standalone businesses or may involve the simultaneous acquisition of multiple companies to create the foundation to achieve our investment goals. The unifying theme of our investments is a cohesive strategy, developed at the outset, that forms the basis of an execution plan that is rigorously pursued to improve the underlying business operations, accelerate growth, create and/or enhance competitive differentiation and substantially boost profitability.

INVESTMENT TEAM

Richard Fay

Richard Fay, Managing Partner

Over 20 years experience in private equity, structured products and as a founder / operator with a focus on healthcare, industrials and technology.
LinkedIn


Christopher Yamamoto

Christopher Yamamoto, Managing Partner

Over 20 years experience in private equity, mergers & acquisitions and strategy with a focus on medical technology, life sciences and industrials.
LinkedIn


Michael Carter, Principal

Over 10 years experience in private equity and investment banking with a focus on mergers & acquisitions and structured products across various industry verticals.
LinkedIn

OPERATING PARTNERS

Bob Roda
Medical Device
Chief Executive Officer

LinkedIn

Chris Gildea
Medical Device
Chief Operating Officer

LinkedIn

Gary Gemignani
Pharmaceutical
Chief Financial Officer

LinkedIn

Dr. Mohamad Hamade
Institutional Healthcare Investor (Middle East), Hospital Chairman & Physician

LinkedIn

Tony Borowicz
Medical Device
Contract Manufacturing Senior Executive

LinkedIn